FDA Brief

Warning letters Animal

FDA warning letter to

Wilson Livestock

High riskIssued Jul 24Posted Sep 29Center for Veterinary Medicine

Wilson Livestock sold a heifer with excess desfuroylceftiofur residue and used a cephalosporin drug outside approved labeling for disease prevention.

What happened

FDA conducted a compliance follow-up inspection of Wilson Livestock's livestock dealing operation from January 22 through March 11, 2026. FDA found that the company sold a heifer for slaughter whose kidney tissue contained desfuroylceftiofur at 0.961 ppm, above the 0.4 ppm tolerance, did not maintain treatment records for drugs given to cattle, and administered a cephalosporin drug to all cattle for disease prevention before releasing them into fields. The letter states that no written response to the Form FDA 483 was received.

What FDA found

  1. FDA found a kidney residue of desfuroylceftiofur at 0.961 ppm in a heifer sold for slaughter, above the 0.4 ppm tolerance.

    21 CFR 556.113(b)(1)(i); FD&C Act Section 402(a)(2)(C)(ii) [21 U.S.C. § 342(a)(2)(C)(ii)]
  2. The company did not maintain treatment records for drugs given to cattle, so medicated animals with harmful residues could enter the food supply.

    FD&C Act Section 402(a)(4) [21 U.S.C. § 342(a)(4)]
  3. The company gave a cephalosporin drug to all cattle for disease prevention before releasing them into fields, which is not approved labeling and is a prohibited extralabel use.

    21 CFR 530.41(a)(13)(i); 21 CFR 530.3(a)
  4. By using the drug contrary to its approved labeling and outside the allowed extralabel rules, the company caused the new animal drug to be unsafe and adulterated.

    FD&C Act Section 501(a)(5) [21 U.S.C. § 351(a)(5)]; FD&C Act Section 512 [21 U.S.C. § 360b]

What FDA wants

Within 15 working days of receipt, notify FDA in writing of the specific steps taken to correct the violations, explain steps to prevent recurrence, and include related documentation. If corrective actions cannot be completed in that time, state the reason for delay and when they will be completed.

Who should pay attention

  • livestock dealers and ranchers selling cattle for slaughter
  • beef producers using cephalosporin drugs in cattle
  • slaughterhouses and meat processors receiving cattle from dealers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Karcz Nation, LLC

    Wisconsin dairy farm sold cows for slaughter with illegal antibiotic residues after off-label ceftiofur and ampicillin use, FDA says.

    High risk
  2. John & Nicole Santos Dairy

    John & Nicole Santos Dairy of Hilmar, California sold dairy cows for slaughter containing ampicillin residues above the legal limit.

    High risk
  3. Tex-Stein Dairy

    Tex-Stein Dairy sold a dairy cow for slaughter with illegal meloxicam and ceftiofur residues and kept incomplete treatment records.

    High risk
  4. Island Kinetics, Inc. d.b.a. CoValence Laboratories

    Island Kinetics (CoValence Laboratories) made OTC acne drugs without process validation and shipped unapproved, misbranded acne products.

    High risk